Overview

Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke

Status:
Not yet recruiting
Trial end date:
2024-03-13
Target enrollment:
Participant gender:
Summary
To explore the safety and efficacy of edaravone dexborneol for the treatment of acute ischemic stroke patients who received thrombolysis.
Phase:
Phase 2
Details
Lead Sponsor:
Huashan Hospital
Collaborator:
Shanghai Stroke Association
Treatments:
Edaravone